\(
\def\WIPO{World Intellectual Property Organisation}
\)
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
2015
Formatos
| Formato | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Files
Detalles
Título
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
Variante de título
Economic Research Working Paper No. 24
Autor
Tipo de elemento
Working paper
Descripción
14 pages ; [28] cm.
ISSN
2957-8256
Resúmen
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.
Serie
Tipo de archivo
Digital publication.
Serie
Economics Working Papers.
Traducciones
Publicado
Geneva, Switzerland : [World Intellectual Property Organization], 2015.
Lengua(s)
eng
El registro aparece en